Amid speedy trials, access to safe COVID-19 vaccines is priority: experts
Pharmaceutical executives and the Department of Science and Technology said the target availability of a COVID-19 vaccine by mid-2021 is still “very optimistic” even with the accelerated process for clinical trials.